These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 20606378)
21. Comparison of the neutralizing and ELISA antibody titres to human cytomegalovirus (HCMV) in human sera and in gamma globulin preparations. Schmitz H; Essuman S J Med Virol; 1986 Oct; 20(2):177-82. PubMed ID: 2430051 [TBL] [Abstract][Full Text] [Related]
22. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Blum A; Giladi M; Weinberg M; Kaplan G; Pasternack H; Laniado S; Miller H Am J Cardiol; 1998 Apr; 81(7):866-8. PubMed ID: 9555776 [TBL] [Abstract][Full Text] [Related]
23. Role of pentamer complex-specific and IgG subclass 3 antibodies in HCMV hyperimmunoglobulin and standard intravenous IgG preparations. Schampera MS; Arellano-Galindo J; Kagan KO; Adler SP; Jahn G; Hamprecht K Med Microbiol Immunol; 2019 Feb; 208(1):69-80. PubMed ID: 30203132 [TBL] [Abstract][Full Text] [Related]
24. Assessment of methods for cytomegalovirus antibody testing of blood donations. Chung A; Chang W; Leung MK; Ofosu FA; Moore BP Vox Sang; 1984; 47(5):343-7. PubMed ID: 6095530 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of neutralizing antibody titers against human cytomegalovirus in intravenous gamma globulin preparations. Roy DM; Grundy JE Transplantation; 1992 Dec; 54(6):1109-10. PubMed ID: 1334581 [No Abstract] [Full Text] [Related]
27. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT). Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924 [TBL] [Abstract][Full Text] [Related]
28. Assessment of the presence of cytomegalovirus-neutralizing antibody by a plaque-reduction assay. Lewis RB; Matzke DS; Albrecht TB; Pollard RB Rev Infect Dis; 1986; 8 Suppl 4():S434-8. PubMed ID: 3018894 [TBL] [Abstract][Full Text] [Related]
29. Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection. Van der Giessen M; van den Berg AP; van der Bij W; Postma S; van Son WJ; The TH Clin Exp Immunol; 1990 Apr; 80(1):56-61. PubMed ID: 2157567 [TBL] [Abstract][Full Text] [Related]
30. [Relationship between the symptomatic cytomegalovirus infection and the fluctuation of anti-CMV antibodies in patient after renal transplantation]. Miyamoto N; Takamura Y Rinsho Byori; 1992 Feb; 40(2):189-93. PubMed ID: 1316499 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of CMV total antibody EIA. An enzyme immunoassay for detection of antibodies to cytomegalovirus. Chairez R; Cesario AJ; Barrett JE; Schleicher JB Diagn Microbiol Infect Dis; 1985 Sep; 3(5):403-10. PubMed ID: 2992866 [TBL] [Abstract][Full Text] [Related]
33. [Persistence of antibodies of the IgG class against cytomegaloviruses in blood donors]. Eichler C; Kaden J; Blauärmel O; Zimmermann G; Adamczyk G Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):560-9. PubMed ID: 2446998 [TBL] [Abstract][Full Text] [Related]
34. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins. Chehimi J; Peppard J; Emanuel D Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341 [TBL] [Abstract][Full Text] [Related]
35. [Preparation of a specific anti-cytomegalovirus immunoglobulin for intravenous injection]. Maniez-Montreuil M; Dupressoir-Burlet MV; Martinache L; Goudemand M Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):375-82. PubMed ID: 6091229 [TBL] [Abstract][Full Text] [Related]
36. [Detection of cytomegalovirus antibody activity in intravenous preparations of immunoglobulins with parallel-line method]. Israfilov AG; Davletbaeva LR; Magazov RSh; Patrakova AZ; Tuĭgunov MM Vestn Ross Akad Med Nauk; 2007; (1):26-8. PubMed ID: 17338377 [TBL] [Abstract][Full Text] [Related]
37. Prophylactic intravenous immunoglobulin injections to mothers with primary cytomegalovirus infection. Tanimura K; Tairaku S; Deguchi M; Sonoyama A; Morizane M; Ebina Y; Morioka I; Yamada H Kobe J Med Sci; 2014 Jul; 60(2):E25-9. PubMed ID: 25339256 [TBL] [Abstract][Full Text] [Related]
38. Successful treatment for active cytomegalovirus infection by cytomegalovirus antibody-enriched immunoglobulin in a renal transplant recipient. Hiyoshi M; Takubo T; Tagawa S; Hashimoto S; Tatsumi N Kansenshogaku Zasshi; 1997 Dec; 71(12):1257-60. PubMed ID: 9483889 [TBL] [Abstract][Full Text] [Related]
39. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates. Mussi-Pinhata MM; Pinto PC; Yamamoto AY; Berencsi K; de Souza CB; Andrea M; Duarte G; Jorge SM J Med Virol; 2003 Feb; 69(2):232-9. PubMed ID: 12683413 [TBL] [Abstract][Full Text] [Related]